review Open AccessTop 1% cited
Microtubule-binding agents: a dynamic field of cancer therapeutics
Nature Reviews Drug Discovery · 2010 · Vol. 9(10) · pp. 790–803
Charles Dumontet✉(Lyon College)Mary Ann Jordan(University of California, Santa Barbara)
Microtubule and mitosis dynamicsCancer Treatment and Pharmacology14-3-3 protein interactionsMicrotubuleTubulinCytoskeletonBiologyCancer therapyComputational biologyCancerChemistryCell biologyBiochemistry
MeSH terms
AnimalsAntineoplastic AgentsHumansMicrotubulesNeoplasm ProteinsNeoplasmsProtein Binding
Funding
- Association pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- University of California, Santa Barbara
Citations
1,682
FWCI
28.43
field-weighted impact
References
222
Percentile
100%
vs. same field & year
Citations per year
Cited by
Currents and futuristic trends in treatment of blood cancer
International Journal of Pharmacology and Clinical Research · 2025 · 0 citations
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
Materials Science and Engineering C · 2019 · 827 citations
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
Neuroscience Letters · 2014 · 422 citations
Thiazole-containing compounds as therapeutic targets for cancer therapy
European Journal of Medicinal Chemistry · 2019 · 361 citations
Strategies and challenges for the next generation of antibody–drug conjugates
Nature Reviews Drug Discovery · 2017 · 2,087 citations
References
Microtubules as a target for anticancer drugs
Nature reviews. Cancer · 2004 · 4,414 citations
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Cancer Research · 2008 · 1,659 citations
The role of glutathione-S-transferase in anti-cancer drug resistance
Oncogene · 2003 · 1,337 citations
Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
Journal of the American Chemical Society · 1971 · 4,031 citations
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies
Clinical Cancer Research · 2004 · 798 citations
Cremophor EL
European Journal of Cancer · 2001 · 1,626 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.